We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-4.46%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$10.5B
AUM Growth
+$4.68B
Cap. Flow
+$4.98B
Cap. Flow %
47.59%
Top 10 Hldgs %
29.39%
Holding
7,240
New
774
Increased
2,864
Reduced
2,421
Closed
823

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$413M
2
MSFT icon
Microsoft
MSFT
+$342M
3
AMZN icon
Amazon
AMZN
+$210M
4
TSLA icon
Tesla
TSLA
+$130M
5
NVDA icon
NVIDIA
NVDA
+$126M

Sector Composition

Rank Sector Weight
1 Technology 30.51%
2 Consumer Discretionary 11.81%
3 Healthcare 9.9%
4 Communication Services 9.49%
5 Financials 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWC icon
4726
iShares Micro-Cap ETF
IWC
$1.52B
$7K ﹤0.01%
51
-13,777
-100% -$1.77M
IWS icon
4727
iShares Russell Mid-Cap Value ETF
IWS
$16.1B
$7K ﹤0.01%
61
-548
-90% -$64.5K
IXN icon
4728
iShares Global Tech ETF
IXN
$9.42B
$7K ﹤0.01%
117
-2
-2% -$115
KPRX icon
4729
Kiora Pharmaceuticals
KPRX
$11.3M
$7K ﹤0.01%
30
+29
+2,900% +$7.58K
LBTYA icon
4730
Liberty Global Class A
LBTYA
$3.57B
$7K ﹤0.01%
278
-1,344
-83% -$35.6K
LMB icon
4731
Limbach Holdings
LMB
$543M
$7K ﹤0.01%
+997
New +$7.84K
LOB icon
4732
Live Oak Bancshares
LOB
$2B
$7K ﹤0.01%
135
-2,082
-94% -$133K
LTH icon
4733
Life Time Group Holdings
LTH
$10.1B
$7K ﹤0.01%
467
+75
+19% +$1.14K
MBCN
4734
DELISTED
Middlefield Banc Corp
MBCN
$7K ﹤0.01%
307
+157
+105% +$3.98K
MBOT icon
4735
Microbot Medical
MBOT
$104M
$7K ﹤0.01%
+1,112
New +$6.52K
MBRX icon
4736
Moleculin Biotech
MBRX
$4.35M
$7K ﹤0.01%
+11
New +$6.31K
MITQ icon
4737
Moving iMage Technologies
MITQ
$5.47M
$7K ﹤0.01%
5,529
+1,937
+54% +$2.78K
MSBI icon
4738
Midland States Bancorp
MSBI
$693M
$7K ﹤0.01%
232
-775
-77% -$22.2K
NAT icon
4739
Nordic American Tanker
NAT
$1.42B
$7K ﹤0.01%
3,369
-24,151
-88% -$42.8K
NEGG icon
4740
Newegg Commerce
NEGG
$392M
$7K ﹤0.01%
55
-103
-65% -$13.3K
NUVB icon
4741
Nuvation Bio
NUVB
$2.18B
$7K ﹤0.01%
1,238
-1,350
-52% -$7.58K
NX icon
4742
Quanex
NX
$962M
$7K ﹤0.01%
344
-418
-55% -$9.51K
OCUL icon
4743
Ocular Therapeutix
OCUL
$2.2B
$7K ﹤0.01%
1,423
-1,429
-50% -$7.92K
PAHC icon
4744
Phibro Animal Health
PAHC
$1.39B
$7K ﹤0.01%
371
-281
-43% -$5.67K
PAM icon
4745
Pampa Energía
PAM
$4.23B
$7K ﹤0.01%
300
PIO icon
4746
Invesco Global Water ETF
PIO
$275M
$7K ﹤0.01%
+195
New +$7.36K
PLX icon
4747
Protalix BioTherapeutics
PLX
$179M
$7K ﹤0.01%
6,465
+6,393
+8,879% +$5.86K
PRPO icon
4748
Precipio
PRPO
$42M
$7K ﹤0.01%
253
-90
-26% -$2.5K
PSC icon
4749
Principal Exchange-Traded Funds Principal US Small-Cap ETF
PSC
$2.34B
$7K ﹤0.01%
161
-198
-55% -$8.8K
PSNL icon
4750
Personalis
PSNL
$1.5B
$7K ﹤0.01%
752
-251
-25% -$2.6K

Similar funds

Tower Research Capital (TRC)'s Q1 2022 Portfolio in Review

As of Q1 2022, Tower Research Capital (TRC) held 7,240 positions worth $10.5B, up 81% from $5.78B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $4.98B of net new capital in Q1 2022, opening 774 new positions and adding to 2,864 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $45.1M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2022 buy was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2022, an estimated $413M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $45.1M.
  • Tower Research Capital (TRC) fully exited State Street Technology Select Sector SPDR ETF in Q1 2022, selling an estimated $51.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $10.5B portfolio in Q1 2022.
  • Tower Research Capital (TRC) opened 774 new positions and closed 823 in Q1 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 81% quarter-over-quarter to $10.5B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2022, filed 12 May 2022.